Preoperative Immunonutrition in Patients Undergoing Spine Surgery
Primary Purpose
Arthrosis; Spine
Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Immuno-nutrition
Sponsored by
About this trial
This is an interventional supportive care trial for Arthrosis; Spine
Eligibility Criteria
Inclusion Criteria:
- male and female sex, of all ethnicities, aged over 60
- arthrodesis involving ≥ 6 vertebrae
- American Society of Anesthesiology (ASA) risk: 1, 2, or 3
- Absence of neurological or psychiatric disorders
- Signing of informed consent and consent to collaborate in all study procedures
- Patients who meet the clinical requirements to undergo their first spinal surgery
Exclusion Criteria:
- American Society of Anesthesiology (ASA) risk: 4
- No cervical arthrodesis
- Diagnosis of neurological or psychiatric disorders
- Revisions
- Therapy with other supplements at the time of the first visit 0
- Known allergy or adverse food reactions
- Chronic inflammatory or autoimmune diseases (e.g. rheumatoid arthritis)
- Gastrointestinal disorders
- Conditions that do not allow to undergo surgery
Sites / Locations
- IRCCS Istituto Ortopedico GaleazziRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Supplemented patients
Standard of care
Arm Description
Outcomes
Primary Outcome Measures
Amelioration of functions evaluated through the Oswestry Disability Index (ODI)
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05372289
Brief Title
Preoperative Immunonutrition in Patients Undergoing Spine Surgery
Official Title
Immunonnutrition in Spine Surgery to Improve Patient's Outcome: a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 16, 2022 (Actual)
Primary Completion Date
February 2024 (Anticipated)
Study Completion Date
February 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Istituto Ortopedico Galeazzi
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
A malnutritional status is known to be associated with altered immune function, reduced function, and worsen outcomes after orthopedic surgery. Medical and surgical complications are not uncommon in Orthopedics and infection rates are potentially life-threatening complications, with the highest morbidity, mortality, and healthcare costs. Most patients undergoing orthopedic surgery are elderly, malnourished, osteosarcopenic, sedentary, anemic, and suffer from low levels of vitamin D. A mono-nutrient supplement may be not sufficient for supporting the arthrodesis techniques, which are invasive open surgeries procedures with significant blood losses and the need of transfusions. In this therapeutic area, immuno-nutrition has been used in spine surgery, with the reduction of complications, revisions, and readmissions. In addition, prosthetic surgery outcomes have been observed to ameliorate by using this nutritional support. Therefore, preoperative oral immuno-nutrition therapy may be applied in older adults undergoing spine surgery to improve patients' outcomes and reduce complications.
This is a randomized, controlled, open-label, 2-arm non-parallel-group, single-center interventional study to assess the efficacy of an immuno-nutrition therapy vs. hospital standard of care in spine surgery to improve patients' outcomes. This is a single primary endpoint study. A total of 136 patients from IRCCS Orthopedic Institute Galeazzi in Italy will be recruited and assigned in a 1:1 ratio to the treatment arm.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arthrosis; Spine
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
In this study, the primary endpoint assessors, who are assessing parameters constituting the primary endpoints, will be masked to the treatment regimen. Any personnel involved with the statistical analysis and interpretation of the data and results will be masked to the treatment regimen until database lock.
Allocation
Randomized
Enrollment
136 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Supplemented patients
Arm Type
Experimental
Arm Title
Standard of care
Arm Type
No Intervention
Intervention Type
Dietary Supplement
Intervention Name(s)
Immuno-nutrition
Intervention Description
The experimental group of 68 older adults will be subjected to a preoperative immuno-nutrition for 30 days prior to surgery and up to 3 days after surgery. The oral feed provides energy, omega-3 fatty acids, arginine, nucleotides, and soluble fibre.
Primary Outcome Measure Information:
Title
Amelioration of functions evaluated through the Oswestry Disability Index (ODI)
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
male and female sex, of all ethnicities, aged over 60
arthrodesis involving ≥ 6 vertebrae
American Society of Anesthesiology (ASA) risk: 1, 2, or 3
Absence of neurological or psychiatric disorders
Signing of informed consent and consent to collaborate in all study procedures
Patients who meet the clinical requirements to undergo their first spinal surgery
Exclusion Criteria:
American Society of Anesthesiology (ASA) risk: 4
No cervical arthrodesis
Diagnosis of neurological or psychiatric disorders
Revisions
Therapy with other supplements at the time of the first visit 0
Known allergy or adverse food reactions
Chronic inflammatory or autoimmune diseases (e.g. rheumatoid arthritis)
Gastrointestinal disorders
Conditions that do not allow to undergo surgery
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elena Cittera
Phone
00390283502224
Email
elena.cittera@grupposandonato.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matteo Briguglio
Organizational Affiliation
IRCCS Istituto Ortopedico Galeazzi
Official's Role
Principal Investigator
Facility Information:
Facility Name
IRCCS Istituto Ortopedico Galeazzi
City
Milan
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elena Cittera
Phone
00390283502224
Email
elena.cittera@grupposandonato.it
First Name & Middle Initial & Last Name & Degree
Matteo Briguglio
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Preoperative Immunonutrition in Patients Undergoing Spine Surgery
We'll reach out to this number within 24 hrs